Works matching IS 10781552 AND DT 2019 AND VI 25

Results: 317

Abstracts.

Published in:: 2019
Publication type:: Abstract

Congratulations to the OPP Best Paper Awardees.

Published in:: Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2064, doi. 10.1177/1078155219882897
Publication type:: Article

Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1995, doi. 10.1177/1078155219866500

By:

Djebbari, Faouzi;
Tatarczuch, Maciej;
Panitsas, Fotios;
Vallance, Grant;
Sultanova, Manuela;
Kothari, Jaimal;
Ramasamy, Karthik;
Peniket, Andy

Publication type:

Article

Apalutamide: A new agent in the management of prostate cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1968, doi. 10.1177/1078155219864424

By:

May, Megan B;
Glode, Ashley E

Publication type:

Article

Implementation of an online chemotherapy checking training module enhances scope of practice and ensures competency.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1987, doi. 10.1177/1078155219864406

By:

Garg, Manju;
Dobish, Roxanne;
Kempston, Annette;
Burns, Robin;
Folkman, Frances;
Chambers, Carole R

Publication type:

Article

Demonstrating the value of the oncology pharmacist within the healthcare team.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1945, doi. 10.1177/1078155219859424

By:

M Segal, Eve;
Bates, Jill;
Fleszar, Sara L;
Holle, Lisa M;
Kennerly-Shah, Julie;
Rockey, Michelle;
Jeffers, Kate D

Publication type:

Article

Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2060, doi. 10.1177/1078155219858177

By:

Yilmaz, Melek Tugce;
Elmali, Aysenur;
Yazici, Gozde

Publication type:

Article

Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2062, doi. 10.1177/1078155219858176

By:

Ürün, Yüksel;
Yaşar, H Arzu;
Turna, Hande;
Kılıçkap, Saadettin;
Sezer, Ahmet;
Öksüzoğlu, Berna;
Özdemir, Nuriye;
Şendur, MA Nahit;
Abalı, Hüseyin

Publication type:

Article

Impact of therapeutic modalities on disease-specific survival in older adults with glioblastoma: A single-institution retrospective cohort study.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1999, doi. 10.1177/1078155219857792

By:

Iskandar, Andrew S;
Kerr, Wesley T;
Hwang, Andrew;
Farrell, Stephanie;
Plaxe, Steven C;
Dasanu, Constantin A

Publication type:

Article

Severe hypersensitivity allergic reaction to filgrastim in a healthy stem cell donor.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2056, doi. 10.1177/1078155219856419

By:

Doval, Divya;
Choudhary, Dharma;
Sharma, Sanjeev K;
Khandelwal, Vipin

Publication type:

Article

Economic sustainability of nivolumab at flat dose for second-line treatment of metastatic non-small cell lung cancer in real life.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2059, doi. 10.1177/1078155219854125

By:

Giuliani, Jacopo;
Albanese, Vito;
Ponturo, Giovanni;
Bonetti, Andrea

Publication type:

Article

Evaluation of a safe handling and cytotoxic drug preparation training program for oncology pharmacy practitioners.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1979, doi. 10.1177/1078155219853612

By:

Ozakin, Gozde Yesilyaprak;
Ciftci, A Haluk;
Sanci, Kadriye

Publication type:

Article

What patient assessment skills are required by pharmacists prescribing systemic anti-cancer therapy? A consensus study.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1933, doi. 10.1177/1078155219841118

By:

Allison, Jennifer;
Fisher, Julie;
Souter, Caroline;
Bennie, Marion

Publication type:

Article

Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1927, doi. 10.1177/1078155219835597

By:

Keating, Matthew J;
Giscombe, Lisa;
Tannous, Toufic;
Reddy, Nishitha;
Mukkamalla, Shiva Kumar R;
DeSouza, Andre;
Rathore, Ritesh

Publication type:

Article

The role of the pharmacist in improving medication beliefs and adherence in cancer patients.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1916, doi. 10.1177/1078155219831377

By:

Birand, Nevzat;
Boşnak, Ahmet Sami;
Diker, Ömer;
Abdikarim, Abdi;
Başgut, Bilgen

Publication type:

Article

Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2052, doi. 10.1177/1078155219830166

By:

Dasanu, Constantin A

Publication type:

Article

Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1907, doi. 10.1177/1078155219828806

By:

Patel, Priya;
Nathan, Paul C;
Walker, Scott E;
Zupanec, Sue;
Volpe, Jocelyne;
Dupuis, L Lee

Publication type:

Article

Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1897, doi. 10.1177/1078155219827637

By:

Patel, Krish;
Sudhir, Vinjamuri S;
Kabadi, Shaum;
Huang, Joanna C;
Porwal, Sanchita;
Thakkar, Kushan;
Pagel, John M

Publication type:

Article

Continuous angiogenesis inhibition in the treatment for von Hippel–Lindau-related hemangioblastomas of retina and spinal cord.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2049, doi. 10.1177/1078155219827635

By:

Salim, Derya Kıvrak

Publication type:

Article

Severe left atrial enlargement due to carfilzomib use in multiple myeloma.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2045, doi. 10.1177/1078155218825298

By:

Dasanu, Constantin A;
Plaxe, Steven C;
Popescu, Iliana M;
Gupta, Varun;
Sontz, Eric;
Codreanu, Ion

Publication type:

Article

Propofol-based balanced anesthesia is safer in pediatric radiotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1891, doi. 10.1177/1078155218825296

By:

Yıldırım, İlknur;
İ Çelik, Ayça;
B Bay, Sema;
Pasin, Özge;
Tütüncü, Ayşe Ç

Publication type:

Article

Simulation program of a cytotoxic compounding robot for monoclonal antibodies and anti-infectious sterile drug preparation.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1873, doi. 10.1177/1078155218823911

By:

Deljehier, Thomas;
Bouguéon, Guillaume;
Heloury, Jeanne;
Moreno, Valérie;
Berroneau, Aude;
Crauste-Manciet, Sylvie

Publication type:

Article

Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1867, doi. 10.1177/1078155218822707

By:

Lee, Jenessa;
Graham, Anastasia;
Sion, Amy

Publication type:

Article

Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1860, doi. 10.1177/1078155218821406

By:

Roy, Amanda M;
Lei, Matthew;
Lou, Uvette

Publication type:

Article

Comparison of quality of life of patients on treatment with cisplatin and gemcitabine, carboplatin and gemcitabine, carboplatin and paclitaxel, carboplatin and pemetrexed for non-small cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1853, doi. 10.1177/1078155218820932

By:

Saranya, K;
Sreejith, K;
Ajaykumar

Publication type:

Article

Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1846, doi. 10.1177/1078155218820927

By:

Nasser, Sahar M;
Sahal, Arwa;
Hamad, Anas;
Elazzazy, Shereen

Publication type:

Article

A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2041, doi. 10.1177/1078155218820108

By:

Hill, Hailey;
Arnall, Justin;
Janes, Amanda;
Hatley, Crystal;
Swift, Kristen;
Hargett, Christy;
Howell, Theresa;
Griffin, Sarah;
Larck, Christopher;
Park, Stephen

Publication type:

Article

Tamoxifen-induced hepatotoxicity caused by drug interaction with direct-acting antiviral agents for hepatitis C.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2038, doi. 10.1177/1078155218819742

By:

Wyffels, Klara;
Horsmans, Yves

Publication type:

Article

Dose-related periorbital edema following sorafenib in a patient with acute myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2035, doi. 10.1177/1078155218818719

By:

Freyer, Craig W;
Mangan, James K

Publication type:

Article

Abiraterone experience in a patient with metastatic castration-resistant prostate cancer on hemodialysis.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2031, doi. 10.1177/1078155218818250

By:

Karakurt Eryılmaz, Melek;
Karaağaç, Mustafa

Publication type:

Article

Evaluation of the clinical impact of concomitant acid suppression therapy in colorectal cancer patients treated with capecitabine monotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1839, doi. 10.1177/1078155218818237

By:

Rhinehart, Hannah E;
Phillips, Michelle A;
Wade, Nathaniel;
Baran, Andrea

Publication type:

Article

Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2027, doi. 10.1177/1078155218817817

By:

Chen, Jason;
Ngo, Dat;
Rosenthal, Joseph

Publication type:

Article

FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1831, doi. 10.1177/1078155218817816

By:

Mustafa, Omima;
Abdalla, Khalid;
AlAzmi, Aeshah A;
Elimam, Naglla;
Abrar, Mohammed Burhan;
Jastaniah, Wasil

Publication type:

Article

Incidence and attributes of chemotherapy induced myelotoxicity, anemia and neutropenia in adults with cancer in Nepal: A cross-sectional observational study.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1823, doi. 10.1177/1078155218817815

By:

Sah, Shiv K.;
Karn, Ambuj;
Shah, Aarati;
Paudel, Bishnu D.;
Adhikari, Kajiram;
Acharya, Bibek;
Chapagain, Sandhya

Publication type:

Article

Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2010, doi. 10.1177/1078155218816768

By:

Kakiuchi, Seiji;
Yakushijin, Kimikazu;
Sakai, Rina;
Kawaguchi, Koji;
Higashime, Ako;
Kurata, Keiji;
Ichikawa, Hiroya;
Nagao, Shigeki;
Rikitake, Junpei;
Kiyota, Naomi;
Matsuoka, Hiroshi;
Minami, Hironobu

Publication type:

Article

Evaluation of anti-infectives prescriptions in a pediatric hemato-oncological center: A retrospective study.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1811, doi. 10.1177/1078155218816779

By:

Diop, Boubacar BF;
Cheikh, Amine;
Attjioui, Houda;
Ajaja, Mohamed R;
Mefetah, Hafid;
Bouatia, Mustapha

Publication type:

Article

Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2023, doi. 10.1177/1078155218816777

By:

Hatakeyama, Yukihisa;
Ohnishi, Hisashi;
Suda, Kentaro;
Okamura, Kayoko;
Shimada, Temiko;
Yoshimura, Sho

Publication type:

Article

Vinblastine-induced posterior reversible encephalopathy syndrome.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2019, doi. 10.1177/1078155218816776

By:

Ayesh (Haj Yousef), Mahmoud H;
Eyadeh, Ahmed;
Rawashdeh, Rand AL;
Khasawneh, Ruba;
Saleh, Judy A;
Jibreel, Malak J

Publication type:

Article

Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2016, doi. 10.1177/1078155218816775

By:

Iskandar, Andrew;
Hwang, Andrew;
Dasanu, Constantin A

Publication type:

Article

Wound healing complications with lenvatinib identified in a pharmacovigilance database.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1817, doi. 10.1177/1078155218817109

By:

Cheng, Connie;
Nayernama, Afrouz;
Christopher Jones, S;
Casey, Denise;
Waldron, Peter E

Publication type:

Article

Pemetrexed-induced severe rhabdomyolysis in lung cancer: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2007, doi. 10.1177/1078155218816767

By:

Sullivan, Kevin;
Lee, Chung-Shien

Publication type:

Article

Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2004, doi. 10.1177/1078155218815743

By:

Tilton, Jessica J;
Sadr, Rozhan;
Groo, Vicki L

Publication type:

Article

The role of targeted therapy in thymic carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1712, doi. 10.1177/1078155219852758

By:

Krishnan, Mridula;
Ganti, Apar K

Publication type:

Article

Concomitant use of capecitabine and proton pump inhibitors – Is it safe?

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1705, doi. 10.1177/1078155219846952

By:

Cheng, Vian;
Lemos, Mario de;
Hunter, Nicole;
Badry, Nadine;
Lemos, Jane de

Publication type:

Article

Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1719, doi. 10.1177/1078155219838614

By:

Hwang, Andrew;
Iskandar, Andrew S;
Kerr, Wesley T;
Farrell, Stephanie;
Plaxe, Steven C;
Dasanu, Constantin A

Publication type:

Article

A first time report on the cooccurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1801, doi. 10.1177/1078155219837331

By:

Afacan Öztürk, Hacer Berna;
Albayrak, Murat;
Pala Öztürk, Çiğdem;
Yıldız, Abdulkerim;
Maral, Senem;
Önder, Evrim

Publication type:

Article

Layered learning pharmacy practice model in Ethiopia.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1699, doi. 10.1177/1078155218820105

By:

Chargualaf, Michael J;
Giao, Tieumy T;
Abrahamson, Anna C;
Steeb, David;
Law, Miranda;
Bates, Jill;
Nedi, Teshome;
Muluneh, Benyam

Publication type:

Article

A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1692, doi. 10.1177/1078155218815283

By:

Schepers, Allison J;
Jones, Alexis R;
Reeves, Brandi N;
Tuchman, Sascha A;
Bates, Jill S

Publication type:

Article

Interstitial pneumonitis associated with trastuzumab emtansine.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1798, doi. 10.1177/1078155218813716

By:

Alkan, Ali

Publication type:

Article

Altered methotrexate clearance in the treatment of CNS lymphoma with concurrent use of nitrofurantoin for a urinary tract infection.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1794, doi. 10.1177/1078155218813691

By:

Gowarty, Jasmine L;
Patel, Ina J;
Herrington, Jon D

Publication type:

Article